Skip to main content

Table 1 Differences between spontaneous preterm and spontaneous term birth in the human placental proteome

From: Human placental proteomics and exon variant studies link AAT/SERPINA1 with spontaneous preterm birth

Spot

Protein

UniProt-KB

Description

Theoretical pI/ MW (kDa)

Detected pI/ MW (kDa)

Ratio

T vs P

Ch

Ba

26

AAT

P01009

α-1-antitrypsin (isoform 1)

5.37 47 (5.37 44)

4.92 60

(− 1.28)

− 1.50

27

AAT

P01009

α-1-antitrypsin (isoform 1)

4.97 59

− 1.45

− 1.63

38

AAT

P01009

α-1-antitrypsin (isoform 1,2)

4.82 51

− 2.39

(− 2.01)

39

AAT

P01009

α-1-antitrypsin (isoform 1,2)

4.86 51

− 2.16

(− 1.82)

85*

ACTB

P60709

Actin, cytoplasmic 1 (fragment)

5.29 42 (5.29 42)

4.93 18

(1.33)

2.48

18

ALB

P02768

Serum albumin

5.92 69

5.71 66

(− 1.05)

− 1.52

84*

ANXA5

P08758

Annexin A5 (fragment)

4.93 36 (4.93 36)

4.83 18

(1.35)

2.19

67

APCS

P02743

Serum amyloid P-component

6.10 25 (6.12 25)

5.52 25

− 2.42

− 1.62

73

APOA1

P02647

Apolipoprotein A-I

5.56 31

5.09 23

(− 1.44)

− 1.52

58

CLU

P10909

Clusterin (isoform 3)

6.19 32

4.76 36

− 3.08

− 1.96

59

CLU

P10909

Clusterin (isoform 3)

4.82 35

− 2.98

(− 1.75)

60

CLU

P10909

Clusterin (isoform 3)

4.88 34

− 2.99

(− 1.49)

23

CPNE1

Q99829

Copine-1

5.52 59

5.56 63

1.62

1.95

9

EEF2

P13639

Elongation factor 2

6.41 95 (6.42 95)

6.42 95

2.60

1.94

48*

FGB

P02675

Fibrinogen ß chain (C-terminal fragment)

8.54 56 (7.95 51)

5.51 38

− 2.89

(− 1.44)

49*

FGB

P02675

Fibrinogen ß chain (C-terminal fragment)

5.60 39

− 3.04

(− 1.39)

50*

FGB

P02675

Fibrinogen ß chain (C-terminal fragment)

5.71 39

− 2.84

(− 1.44)

51*

FGB

P02675

Fibrinogen ß chain (C-terminal fragment)

5.85 38

− 2.46

(− 1.35)

11

FGG

P02679

Fibrinogen γ (isoform γ-B,A)

5.37 52 (5.24 48)

5.41 95

− 3.59

(− 1.99)

12

FGG

P02679

Fibrinogen γ (isoform γ-B,A)

5.47 94

− 3.42

(− 1.83)

13

FGG

P02679

Fibrinogen γ (isoform γ-B,A)

5.54 94

− 2.91

(− 1.68)

14

FGG

P02679

Fibrinogen γ (isoform γ-B,A)

5.58 94

− 2.67

(− 1.57)

78

FTL

P02792

Ferritin light chain

5.50 20 (5.50 20)

5.50 20

(1.29)

− 2.73

8

GSN

P06396

Gelsolin (isoform 1)

5.90 86 (5.72 83)

5.82 95

− 1.94

− 1.79

89

HBG1/2

P69891/2

Hemoglobin subunit gamma-1/2

6.64 16 (6.71 16)

6.36 12

(1.38)

2.55

28

HNRNPK

P61978

Heterogeneous nuclear ribonucleoprotein K (isoform 1-3)

5.39 51

5.39 57

2.06

(1.33)

17

HSPA5

P11021

78 kDa glucose-regulated protein

5.07 72 (5.01 70)

5.01 71

2.60

2.73

1

ITIH4

Q14624

Inter-α-trypsin inhibitor heavy chain H4 (isoform 1)

6.51 103 (6.11 100)

4.90 137

(− 1.08)

− 1.53

2

ITIH4

Q14624

Inter-α-trypsin inhibitor heavy chain H4 (isoform 1)

4.92 136

(− 1.00)

− 1.58

3

ITIH4

Q14624

Inter-α-trypsin inhibitor heavy chain H4 (isoform 1)

4.94 135

(− 1.05)

− 1.63

4

ITIH4

Q14624

Inter-α-trypsin inhibitor heavy chain H4 (isoform 1)

4.96 135

(− 1.18)

− 1.56

30

KRT8

P05787

Keratin, type II cytoskeletal 8 (isoform 1,2)

5.52 54

5.24 47

− 1.55

(− 1.34)

31

KRT8

P05787

Keratin, type II cytoskeletal 8 (isoform 1,2)

5.33 50

− 2.48

(− 1.54)

54*

KRT8

P05787

Keratin, type II cytoskeletal 8 (isoform 1,2; fragment)

4.85 38

− 5.02

(− 3.82)

57*

KRT8

P05787

Keratin, type II cytoskeletal 8 (isoform 1,2; fragment)

4.79 37

− 4.70

(− 3.49)

5

KRT18

P05783

Keratin, type I cytoskeletal 18

5.34 48 (5.34 48)

5.29 102

− 2.03

(− 1.83)

6

KRT18

P05783

Keratin, type I cytoskeletal 18

5.35 102

− 2.19

(− 2.07)

56*

KRT19

P08727

Keratin, type I cytoskeletal 19 (C-terminal fragment)

5.05 44

4.74 37

− 2.28

(− 1.99)

79

NUDT16

Q96DE0

U8 snoRNA-decapping enzyme (isoform 1)

6.38 21

6.33 21

2.54

(4.78)

10

TF

P02787

Serotransferrin

6.81 77 (6.70 75)

6.02 90

2.43

1.95

80

TAGLN2

P37802

Transgelin-2 (isoform 1,2)

8.41 22 (8.45 22)

5.59 19

− 1.91

− 1.75

41

VIM

P08670

Vimentin

5.05 54 (5.05 54)

4.71 44

− 1.77

− 1.69

24

–

–

–

–

5.53 56

2.01

2.04

  1. Spot numbers are according to Additional file: Fig S1. Descriptions and UniProt accession numbers for the identified spots are shown. Spots belonging to the same protein are clustered. Protein fragments are indicated with asterisks. Specific protein isoforms were validated according to spot positions in the gel and the covered protein sequence, as well as isoform-specific peptides obtained by mass spectrometry. Theoretical spot identifications were calculated according to full or mature (in parentheses) protein sequences, whereas detected spot positions in the gel were determined according to selected marker spots. If the identified spot allowed for the presence of several isoforms, theoretical values were indicated for the most common isoform. Ratio shows the change in mean normalized spot volumes between spontaneous preterm (P) and term (T) birth or between basal (Ba) and chorionic (Ch) plates of the placenta. Changes with no significance (p > 0.05) are denoted by parentheses. Spot 24 was not identified. For more details about protein levels, statistical significance, and protein identification, see Additional file: Tables S1 and S3. Isoelectric point (pI)